These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 21195041

  • 21. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ, Mayer L, Abreu MT.
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract] [Full Text] [Related]

  • 22. Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
    Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R.
    Gut; 2008 Jul; 57(7):893-902. PubMed ID: 18272546
    [Abstract] [Full Text] [Related]

  • 23. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
    Fernández-Bañares F, Hinojosa J, Sánchez-Lombraña JL, Navarro E, Martínez-Salmerón JF, García-Pugés A, González-Huix F, Riera J, González-Lara V, Domínguez-Abascal F, Giné JJ, Moles J, Gomollón F, Gassull MA.
    Am J Gastroenterol; 1999 Feb; 94(2):427-33. PubMed ID: 10022641
    [Abstract] [Full Text] [Related]

  • 24. [Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
    Martínez González J, Busto Bea V, Mesonero Gismero F, Parejo Carbonell S, Garrido E, López San Román A.
    Gastroenterol Hepatol; 2013 Jan; 36(1):7-10. PubMed ID: 23195755
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
    Bresci G, Parisi G, Gambardella L, Banti S, Bertoni M, Rindi G, Capria A.
    Int J Clin Pharmacol Res; 1997 Jan; 17(1):17-22. PubMed ID: 9403349
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M, Rascarachi G, Díez Rodríguez R, Arias Rodríguez L, Del Pozo Maroto E, Muñoz Núñez F.
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract] [Full Text] [Related]

  • 28. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B.
    Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2565-7. PubMed ID: 14714043
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
    Henker J, Müller S, Laass MW, Schreiner A, Schulze J.
    Z Gastroenterol; 2008 Sep 25; 46(9):874-5. PubMed ID: 18810672
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study.
    Assisi RF, GISDI Study Group.
    Minerva Gastroenterol Dietol; 2008 Sep 25; 54(3):231-8. PubMed ID: 18614971
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
    Lee HJ, Jung ES, Lee JH, Hong SP, Kim TI, Kim WH, Cheon JH.
    Hepatogastroenterology; 2012 Sep 25; 59(117):1415-20. PubMed ID: 22683958
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis.
    Pica R, Cassieri C, Cocco A, Zippi M, Marcheggiano A, De Nitto D, Avallone EV, Crispino P, Occhigrossi G, Paoluzi P.
    Dig Liver Dis; 2015 Nov 25; 47(11):933-7. PubMed ID: 26391602
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mesalamine with MMX technology for the treatment of ulcerative colitis.
    Schreiber S, Kamm MA, Lichtenstein GR.
    Expert Rev Gastroenterol Hepatol; 2008 Jun 25; 2(3):299-314. PubMed ID: 19072380
    [Abstract] [Full Text] [Related]

  • 40. "Take your medicine": nonadherence issues in patients with ulcerative colitis.
    Turnbough L, Wilson L.
    Gastroenterol Nurs; 2007 Jun 25; 30(3):212-7; quiz 218-9. PubMed ID: 17568260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.